The effects of canagliflozin compared to sitagliptin on cardiorespiratory fitness in type 2 diabetes mellitus and heart failure with reduced ejection fraction: The CANA‐HF study

por Carbone, Salvatore, Billingsley, Hayley E., Canada, Justin M., Bressi, Edoardo, Rotelli, Brando, Kadariya, Dinesh, Dixon, Dave L., Markley, Roshanak, Trankle, Cory R., Cooke, Richard, Rao, Krishnasree, B. Shah, Keyur, Medina de Chazal, Horacio, Chiabrando, Juan Guido, Vecchié, Alessandra, Dell, Megan, L. Mihalick, Virginia, Bogaev, Roberta, Hart, Linda, Van Tassell, Benjamin W., Arena, Ross, Celi, Francesco S., Abbate, Antonio
Publicado 2020